Adage Capital Partners’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-134,110
| Closed | -$5.15M | – | 974 |
|
|
2023
Q2 | $5.15M | Sell |
134,110
-1,569,890
| -92% | -$60.3M | 0.01% | 666 |
|
|
2023
Q1 | $39.4M | Buy |
1,704,000
+883,822
| +108% | +$20.5M | 0.09% | 264 |
|
|
2022
Q4 | $21.5M | Buy |
820,178
+720,178
| +720% | +$18.9M | 0.05% | 400 |
|
|
2022
Q3 | $1.97M | Sell |
100,000
-50,000
| -33% | -$983K | ﹤0.01% | 856 |
|
|
2022
Q2 | $2.62M | Buy |
+150,000
| New | +$2.62M | 0.01% | 864 |
|